SLQTHIGH SIGNALFINANCIAL10-K

SLQT achieved a dramatic $82M turnaround from loss to profit while simultaneously reducing debt by $298M, though operating cash flow turned significantly negative.

The company's transformation from a $34M loss to $48M profit demonstrates successful execution of their strategic pivot toward healthcare services, supported by substantial debt reduction that strengthens the balance sheet. However, the shift from positive $15M to negative $12M operating cash flow despite strong profitability raises questions about working capital management and cash conversion efficiency that investors should monitor closely.

Comparing 2025-08-21 vs 2024-09-13View on EDGAR →
FINANCIAL ANALYSIS

SLQT delivered impressive top-line growth of 15.5% to $1.5B while executing a remarkable profitability turnaround, swinging from a $34M loss to $48M profit. The company significantly strengthened its balance sheet by reducing total debt 44% and cutting total liabilities by $203M, though this was partially offset by declining cash reserves and deteriorating operating cash flow that turned negative despite strong earnings. The mixed signals of strong profitability gains alongside cash flow challenges suggest the company is in a transitional phase that requires careful monitoring of working capital dynamics.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+239.4%
-$34.1M→$47.6M

Net income grew 239.4% — bottom-line growth signals improving overall business health.

Operating Cash Flow
Cash Flow
-176.6%
$15.2M→-$11.7M

Operating cash flow fell 176.6% — earnings quality concerns; investigate working capital changes and non-cash items.

Inventory
Balance Sheet
+57.3%
$5.6M→$8.8M

Inventory surged 57.3% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.

Total Debt
Balance Sheet
-43.6%
$683.3M→$385.1M

Debt reduced 43.6% — deleveraging strengthens balance sheet and reduces financial risk.

Capital Expenditure
Cash Flow
-35.2%
$3.4M→$2.2M

Capex reduced 35.2% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Cash & Equivalents
Balance Sheet
-24.1%
$42.7M→$32.4M

Cash decreased 24.1% — monitor burn rate and upcoming capital needs.

Total Liabilities
Balance Sheet
-23.2%
$877.1M→$673.8M

Liabilities reduced 23.2% — deleveraging improves balance sheet strength and financial flexibility.

Current Liabilities
Balance Sheet
+22%
$174.6M→$212.9M

Current liabilities rose 22% — increased short-term obligations, watch current ratio.

SG&A Expense
P&L
+16.6%
$141.0M→$164.4M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Revenue
P&L
+15.5%
$1.3B→$1.5B

Revenue growing 15.5% — solid top-line momentum, watch margins for quality of growth.

LANGUAGE CHANGES
NEW — 2025-08-21
PRIOR — 2024-09-13
ADDED
The aggregate market value of the outstanding common stock held by non-affiliates of the Registrant as of December 31, 2024, the last business day of our most recently completed second fiscal quarter, based on the closing price of $3.72 reported by the New York Stock Exchange on that date, was $ 506,928,494 .
Solely for the purposes of this calculation, the Registrant has excluded shares held by the Registrant's directors and executive officers as of December 31, 2024.
The registrant had outstanding 172,816,730 shares of common stock as of July 31, 2025.
In recent years, we have increasingly focused on expanding our healthcare services platform as a natural extension of our core Senior distribution insurance business.
This strategic shift reflects our prioritization of higher-growth opportunities in areas such as pharmacy services and chronic care management through offerings like SelectRx and SelectPatient Management ( SPM ).
+7 more — sign up free →
REMOVED
The aggregate market value of the outstanding common stock held by non-affiliates of the Registrant as of December 29, 2023, the last business day of our most recently completed second fiscal quarter, based on the closing price of $1.37 reported by the New York Stock Exchange on that date, was $ 184,808,919 .
Solely for the purposes of this calculation, the Registrant has excluded shares held by the Registrant's directors and executive officers as of December 29, 2023.
The registrant had outstanding 171,443,421 shares of common stock as of August 31, 2024.
Our proprietary technology allows us to take a broad funnel approach to marketing by analyzing and identifying high-quality consumer leads sourced from a wide variety of online and offline marketing channels including digital marketing, radio, television, and third-party marketing partners.
We monitor our acquisition costs to dynamically allocate our marketing spend to the most attractive channels, benefiting from nearly 40 years of data accumulated through our proprietary, purpose-built technologies.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →